List of insiders holdings for Terns Pharmaceuticals Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Asia GP III L.P. OrbiMed Advisors III Ltd OrbiMed Genesis GP LLC Director 10% Owner | 2023-03-29 17:24:02 | 7,619,135 0 | 7,619,135 | Form 13D |
Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Opportunity LLC Vivo Opportunity Fund L.P. 10% Owner | 2023-02-13 17:57:55 | 4,340,212 0 | 4,340,212 | Form 13G |
LAV Biosciences Fund V L.P. Hopewell Resources Holdings Ltd LAV Aqua Ltd Oriental Spring Venture Ltd 10% Owner | 2024-02-13 17:21:57 | 2,901,566 0 | 2,901,566 | Form 13G |
Burroughs Amy L. Chief Executive Officer | 2024-03-05 18:01:54 | 1,400,000 0 | 1,400,000 | Form 4 |
Zhong Weidong Chief Scientific Officer | 2021-02-04 17:12:41 | 513,520 0 | 513,520 | Form 3 |
Kuriakose Emil Chief Medical Officer | 2024-03-19 19:26:45 | 456,250 0 | 456,250 | Form 3 |
Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner | 2024-04-03 20:47:21 | 0 268,573 | 268,573 | Form 4 |
Russell Kerry Strong Chief Medical Officer | 2022-07-06 20:07:09 | 240,000 0 | 240,000 | Form 4 |
Quirk Erin President, Head of R&D | 2024-01-25 19:17:02 | 225,000 0 | 225,000 | Form 4 |
Vignola Mark J. Chief Financial Officer | 2024-01-25 19:17:37 | 224,649 0 | 224,649 | Form 4 |
Yoon Seokho Bryan COO and General Counsel | 2024-01-25 19:18:25 | 224,649 0 | 224,649 | Form 4 |
KINDLER JEFFREY B Director | 2023-06-14 19:01:16 | 32,000 0 | 32,000 | Form 4 |
Lu Hongbo Director | 2023-06-14 19:01:27 | 32,000 0 | 32,000 | Form 4 |
GORDON CARL L Director 10% Owner | 2023-06-14 19:01:32 | 32,000 0 | 32,000 | Form 4 |
FELLOWS DAVID A Director | 2023-06-14 19:01:40 | 32,000 0 | 32,000 | Form 4 |
Tripuraneni Radhika Director | 2023-06-14 19:02:08 | 32,000 0 | 32,000 | Form 4 |
Taylor Ann Elizabeth Director | 2023-06-14 19:02:14 | 32,000 0 | 32,000 | Form 4 |
Quigley Jill M. Sr. Advisor & Strategy Officer | 2024-01-25 19:18:46 | 30,000 0 | 30,000 | Form 4 |
Sundaram Senthil Vel Chief Executive Officer | 2023-06-02 17:03:03 | 9770 0 | 9770 | Form 4 |
Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) DEERFIELD PARTNERS L.P. Deerfield Mgmt L.P. Possible Member of 10% Group 10% Owner | 2023-10-04 17:09:36 | 0 0 | 0 | Form 13G |